Terminology [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2017-02-18 16:27  – Posting: # 17086
Views: 9,995

Hi BE-proff,

» Rather risky - such methods must be present in our guides otherwise our designs will be rejected...

“Type 1” or “Type 2” was my proposal to introduce an unambiguous terminology. Get the paper at sci-hub. ;-)
On the contrary the Russian guideline (copypasted from the EMA’s) is ambigous (“For example, using 94.12% confidence intervals […] would be acceptable, but there are many acceptable alternatives and the choice of how much alpha to spend at the interim analysis is at the company's discretion”).

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,242 posts in 4,259 threads, 1,397 registered users;
online 11 (0 registered, 11 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 06:51 CET

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5